Atlas Trials

Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer

Clinical trial NCT00103116 · COMPLETED

Trial details

NCT number
NCT00103116
Sponsor
Edward Hirschowitz
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Cancer
Start date
2004-10-01
Primary completion
2008-04-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.